+1 (314) 370-6046 oderKontakt

Rekombinant Anti-HLA-DR Antikörper [IMMU-114] (A324062)

Monoklonal [IMMU-114] Human Antikörper gegen HLA-DR für ELISA, FACS, Functional Assay und In Vivo.

Versandkosten
Vorlaufzeit
Lieferung in 7-10 Werktagen
Telefon
+1 (314) 370-6046
Mo bis Frei, 8am - 4pm AST
Email
orders@antibodies.com
Produktname
Anti-HLA-DR Antibody [IMMU-114] - Low endotoxin, Azide free
Beschreibung
Recombinant human monoclonal [IMMU-114] antibody to HLA-DR.
Anwendungen
ELISA, FACS, Functional Assay, In Vivo
Reaktivität
Human, Cynomolgus Macaque
Wirt
Human
Klonalität
Monoclonal
Klon
IMMU-114
Isotyp
IgG4SP - Human IgG4 with S228P mutation
Leichte Ketten
kappa
Konjugat

Unconjugated

Reinigung
Protein A affinity chromatography.
Konzentration
Reconstitution dependent.
Molekulargewicht
This antibody has a predicted MW of 145.1 kDa.
Reinheit
> 95% (by SDS-PAGE and SEC-HPLC).
Produktform
Lyophilized
Rekonstitution
Reconstitute with 100µl of sterile double-distilled water to bring antibody to 1mg/ml concentration. Gently shake to solubilize completely. Do not vortex!
Formulierung
Lyophilized from 25mM Histadine, pH 6.2, with 8% Sucrose and 0.01% Tween80.
Lagerung
Shipped at 4°C. Lyophilized: Store at -20°C to -80°C. Reconstituted: Aliquot and store at -80°C. Product is stable for one year. Avoid freeze/thaw cycles.
Synonyme
DR alpha chain, DR alpha chain precursor, DRA_HUMAN, DRB1, DRB4, Histocompatibility antigen HLA DR alpha, HLA class II histocompatibility antigen, HLA class II histocompatibility antigen DR alpha chain, HLA DR1B, HLA DR3B, HLA DRA, HLA DRA1, HLA DRB1, HLA DRB3, HLA DRB4, HLA DRB5, HLA-DRA, HLADR4B, HLADRA1, HLADRB, Major histocompatibility complex class II DR alpha, Major histocompatibility complex class II DR beta 1, Major histocompatibility complex class II DR beta 3, Major histocompatibility complex class II DR beta 4, Major histocompatibility complex class II DR beta 5, MGC117330, MHC cell surface glycoprotein, MHC class II antigen DRA, MHC II, MLRW
Haftungsausschluss
Dieses Produkt ist nur für Forschungszwecke bestimmt. Es ist nicht für diagnostische oder therapeutische Zwecke bestimmt.

Alternative Produkte zum Anti-HLA-DR Antikörper [IMMU-114] (A324062)

Oben